Your browser doesn't support javascript.
loading
Development and internal validation of a screening tool for chronic prostatitis (S-CP).
Tohi, Yoichiro; Hijikata, Yasukazu; Sugimoto, Mikio; Kuroda, Hideya; Takei, Mineo; Matsuki, Takakazu; Kamitani, Tsukasa; Kakehi, Yoshiyuki; Fukuhara, Shunichi; Yamamoto, Yosuke.
Afiliação
  • Tohi Y; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-Cho, Kita-Gun, Kagawa, 761-0701, Japan.
  • Hijikata Y; Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sugimoto M; Section of Clinical Epidemiology, Department of Community Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kuroda H; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-Cho, Kita-Gun, Kagawa, 761-0701, Japan. sugimoto.mikio@kagawa-u.ac.jp.
  • Takei M; Kuroda Urology Clinic, Osaka, Japan.
  • Matsuki T; Department of Urology, Harasanshin General Hospital, Fukuoka, Japan.
  • Kamitani T; Matsuki Urology Clinic, Kagawa, Japan.
  • Kakehi Y; Section of Education for Clinical Research, Kyoto University Hospital, Kyoto, Japan.
  • Fukuhara S; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-Cho, Kita-Gun, Kagawa, 761-0701, Japan.
  • Yamamoto Y; Section of Clinical Epidemiology, Department of Community Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
World J Urol ; 41(10): 2759-2765, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37712967
ABSTRACT

PURPOSE:

We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists.

METHODS:

The expert panel proposed the S-CP, which comprises three domains Area of pain or discomfort (6 components), accompanying Symptom (6 components), and Trigger for symptom flares (4 components). We employed logistic regression to predict chronic prostatitis prevalence with the S-CP. We evaluated the predictive performance using data from a representative national survey of Japanese men aged 20 to 84. We calculated the optimism-adjusted area under the curve using bootstrapping. We assessed sensitivity/specificity, likelihood ratio, and predictive value for each cutoff of the S-CP.

RESULTS:

Data were collected for 5,010 men-71 (1.4%) had a chronic prostatitis diagnosis. The apparent and adjusted area under the curve for the S-CP was 0.765 [95% confidence interval (CI) 0.702, 0.829] and 0.761 (0.696, 0.819), respectively. When the cutoff was two of the three domains being positive, sensitivity and specificity were 62.0% (95% CI 49.7, 73.2) and 85.4% (95% CI 84.4, 86.4), respectively. The positive/negative likelihood ratios were 4.2 (95% CI 3.5, 5.2) and 0.45 (95% CI 0.33, 0.60), respectively. The positive/negative predictive values were 5.7 (95% CI 4.2, 7.6) and 99.4 (95% CI 99.1, 99.6), respectively.

CONCLUSION:

The reasonable predictive performance of the S-CP indicated that patients (in the general population) with chronic prostatitis were screened as a first step. Further research would develop another tool for diagnostic support in actual clinical settings.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prostatite Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prostatite Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article